News

MedPage Today on MSN3d
Novel IL-7 Receptor Antagonist Shows Promise in Ulcerative Colitis
Lusvertikimab selectively inhibits IL-7 but not the thymic stromal lymphopoietin (TSLP) axis, Bourreille told attendees. A ...
Reactivity to tumor antigens is important for tumor-infiltrating lymphocyte therapy, study shows
A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...
New guidelines on the role of emerging therapies in managing adults with metastatic brain tumors
The Congress of Neurological Surgeons (CNS) has updated its guidelines on using emerging therapies to treat metastatic brain ...